Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy

August 23, 2016 updated by: Coloplast A/S
To investigate the performance and safety of the three 2-piece convex ostomy appliances

Study Overview

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Humlebæk, Denmark, 3050
        • Coloplast A/S

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Subjects interested in participating in the clinical investigation must comply with the following criteria:

  1. Are at least 18 years of age and have full legal capacity
  2. Have had an ileostomy for at least 3 months.
  3. Have used a convex ostomy appliance for the last month
  4. Have given written informed consent
  5. Have an ileostomy with a diameter of 33mm or less
  6. Have experienced leakage (seeping) under the baseplate at least two times over the last two weeks

Exclusion Criteria:

Subjects complying with the following criteria must be excluded from participation in the clinical investigation:

  1. Have a loop ostomy (also called double-barrel or ostomy with two outlets)
  2. Are pregnant* or breastfeeding.
  3. Currently receiving, or have received within the last 2 months, chemotherapy or radiation therapy.
  4. Currently receiving or have received, within the last month, systemic or local steroid treatment (adrenocortical hormone) in the peristomal area.
  5. Currently suffering from peristomal skin problems (i.e. bleeding or broken skin (weeping skin)).
  6. Known hypersensitivity toward any of the test products

    -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Coloplast Test 1

The subjects are randomised to two arms

In both arms the subjects start measuring the performance of own product to collect baseline data.

In this arm the subjects are randomised to test Coloplast Test1 first and thereafter Coloplast Test 2

Finally the all subject test Coloplast Test 3

Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance
Experimental: Coloplast Test 2

The subjects are randomised to two arms

In both arms the subjects start measuring the performance of own product to collect baseline data.

In this arm the subjects are randomised to test Coloplast Test 2 first and thereafter Coloplast Test 1

Finally the all subject test Coloplast Test 3

Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance
Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of Leakage
Time Frame: 14 days
The degree of leakage was measured with a 32 -point scale developed by Coloplast A/S, where 0 is the best possible outcome (no leakage) and 32 is the worst possible outcome (full leakage under the baseplate)
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Birte P Jakobsen, MD, Coloplast A/S

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

November 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

October 1, 2013

First Submitted That Met QC Criteria

October 1, 2013

First Posted (Estimate)

October 8, 2013

Study Record Updates

Last Update Posted (Estimate)

September 30, 2016

Last Update Submitted That Met QC Criteria

August 23, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CP230

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ileostomy - Stoma

Clinical Trials on Coloplast Test 1

Subscribe